Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Mometasone vs Nasonex in Seasonal Allergic Rhinitis
NCT02109185Phase 1Completed
- Sponsor
- Mylan
- Start
- Sep 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Mylan. Primary endpoint: reflective Total Nasal Symptom Score at 14 days. Started Sep 2013; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02109185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02109185.